Delivery Order SPE2DB24D1007-SPE2DB24FCAJE
Award Date
9/9/24
Potential Completion Date
9/30/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Envarsus XR 4 mg tablets, a specialty medication, with a ceiling value of $3,230.68 and a period of performance through October 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,216.11, is for the supply of Envarsus XR 1 MG tablets. This order is placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Envarsus XR 1 mg tablets. The contract has a ceiling value of $2,931.36 and a completion date of December 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, a firm fixed price delivery order contract valued at $1,465.68 for the supply of Envarsus XR 1 mg tablets. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Envarsus XR 4 mg tablets. The contract has a ceiling value of $1,671.16 and a completion date of January 2, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen is a for-profit organization registered in the System for Award...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of Envarsus XR 1 mg tablets, a prescription medication, to DLA facilities. The contract has a ceiling value of $1,216.11 and a period of performance ending on April 16, 2024. Amerisourcebergen is the prime contractor, and the contract was awarded on a full and open competition basis without any set-aside...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Envarsus XR 1 mg tablets. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order valued at $1,465.68 with a completion date of September 9, 2024. The contract has no set-aside designation. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up...
This is a delivery order awarded by the Defense Logistics Agency's Troop Support Medical division to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $1,216.11 firm-fixed-price contract is for the supply of the prescription drug Envarsus XR 1 MG Tablet, with a performance period ending on May 17, 2024.
AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,615.33, is for the supply of Envarsus XR 4 mg tablets. The contract has a firm fixed price and has a ceiling value of $1,615.33. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $4,041.42 firm fixed price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,256,460 Envarsus XR 4 MG tablets. This contract supports medical supply requirements for government agencies and has an ultimate completion date of August 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering these prescription medications under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999...